Jyong Biotech presents BPH drug candidate at BIO 2026 convention Jul 2, 2026 08:02AM
Jyong Biotech CEO details FDA pathway for botanical BPH drug May 29, 2026 08:02AM
Jyong Biotech updates market strategy for botanical drug candidates Apr 28, 2026 08:35AM
Jyong Biotech completes phase II trial showing cancer prevention benefits Feb 12, 2026 08:32AM
Jyong Biotech reports cholesterol reduction in MCS-8 prostate cancer trial Jan 30, 2026 08:30AM


Dec 19, 2025 09:00AM Jyong Biotech addresses recent share price volatility on NASDAQ
Nov 24, 2025 08:31AM Jyong Biotech signs letter of intent with South Korean firm for drug licensing
Nov 20, 2025 08:32AM Jyong Biotech completes phase II trial for prostate cancer drug MCS-8
Jun 17, 2025 11:14AM Jyong Biotech Ltd. (MENS) IPO opens at $15 after pricing at $7.50 per share
Jun 17, 2025 03:43AM Jyong Biotech (MENS) Prices 2.67M Share IPO at $7.50/sh